ArticleEJHaem2022

Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non-germinal centre B-cell-like diffuse large B-cell lymphoma: A Chinese subgroup analysis of the phase III PHOENIX trial.

Jun Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.